These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8596370)

  • 21. Re: world wide experience with inactivated poliovirus vaccine.
    Arya SC; Agarwal N
    Vaccine; 2009 Jan; 27(1):1. PubMed ID: 18952133
    [No Abstract]   [Full Text] [Related]  

  • 22. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
    Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
    Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What role for inactivated poliovirus vaccine in the eradication endgame?
    Kew O
    J Infect Dis; 2006 May; 193(10):1341-3. PubMed ID: 16619179
    [No Abstract]   [Full Text] [Related]  

  • 24. [The battle in Madrid over poliomyelitis vaccines (1963): science, ideology and power in the first mass immunization campaign in Spain].
    Tuells J
    Gac Sanit; 2019; 33(5):480-484. PubMed ID: 30031656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanded programme on immunization (EPI). Poliomyelitis eradication.
    Wkly Epidemiol Rec; 1994 Feb; 69(7):45-7. PubMed ID: 8155517
    [No Abstract]   [Full Text] [Related]  

  • 26. Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994.
    Ion-Nedelcu N; Strebel PM; Toma F; Biberi-Moroeanu S; Combiescu M; Persu A; Aubert-Combiescu A; Plotkin SA; Sutter RW
    J Infect Dis; 1997 Feb; 175 Suppl 1():S241-6. PubMed ID: 9203723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
    Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliomyelitis in the United States: the final chapter?
    Modlin JF
    JAMA; 2004 Oct; 292(14):1749-51. PubMed ID: 15479943
    [No Abstract]   [Full Text] [Related]  

  • 29. National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global "switch".
    Gamage D; Ginige S; Palihawadana P
    WHO South East Asia J Public Health; 2018 Sep; 7(2):79-83. PubMed ID: 30136665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salk vs. Sabin controversy.
    Puliyel JM
    Indian Pediatr; 1987 Aug; 24(8):690. PubMed ID: 3443513
    [No Abstract]   [Full Text] [Related]  

  • 31. Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21-22 September 2004.
    Wkly Epidemiol Rec; 2004 Nov; 79(45):401-7. PubMed ID: 15625970
    [No Abstract]   [Full Text] [Related]  

  • 32. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper.
    Wkly Epidemiol Rec; 2010 Jun; 85(23):213-28. PubMed ID: 20545051
    [No Abstract]   [Full Text] [Related]  

  • 33. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
    [No Abstract]   [Full Text] [Related]  

  • 34. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand.
    Huang QS; Greening G; Baker MG; Grimwood K; Hewitt J; Hulston D; van Duin L; Fitzsimons A; Garrett N; Graham D; Lennon D; Shimizu H; Miyamura T; Pallansch MA
    Lancet; 2005 Jul 30-Aug 5; 366(9483):394-6. PubMed ID: 16054940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prospects in the field of the antipolio vaccination (author's transl)].
    Focà A
    Ann Sclavo; 1980; 22(1):22-6. PubMed ID: 7018412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leads from the MMWR. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    JAMA; 1988 Jan; 259(3):345-6. PubMed ID: 3336150
    [No Abstract]   [Full Text] [Related]  

  • 37. Some results of the work on mass immunization in the Soviet Union with live poliovirus vaccine prepared from Sabin strains.
    CHUMAKOV MP
    Bull World Health Organ; 1961; 25(1):79-91. PubMed ID: 13879389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivated poliovirus vaccine and vaccine-associated paralytic poliomyelitis.
    Brown B
    JAMA; 1997 Jan 22-29; 277(4):295. PubMed ID: 9002483
    [No Abstract]   [Full Text] [Related]  

  • 39. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Prevots DR; Burr RK; Sutter RW; Murphy TV;
    MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016.
    Zhao D; Ma R; Zhou T; Yang F; Wu J; Sun H; Liu F; Lu L; Li X; Zuo S; Yao W; Yin J
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(49):1357-1361. PubMed ID: 29240729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.